|
|
 |
Vaccine
Information Statements
VISs by language
German-language
VISs
Up-to-date
You
are encouraged to distribute the up-to-date English-language
VIS at the same time
as the translation.
Oral polio vaccine is no longer available
for use in the United States. These VISs are available on our website
for the convenience of people outside the United States who choose
to use them.
|
|
|
German-language VISs
Out-of-date
The translations for some VISs on our website are from previously
published English-language versions that have since been updated.
Unfortunately, IAC is not always able to obtain translations as
updates are issued. Please ensure that your patients receive
information consistent with the current English-language version of
the following VISs.
You are
encouraged to distribute the up-to-date English-language
VIS at the
same time as the translation.
This translation does not contain the
following CDC updates:
- Section 1: The
answer has been rewritten by CDC.
- Section 2: There
are now 2 doses; the first dose is 12-15 months and the second
dose is 4-6 years.
- CDC added information
on MMRV.
- The URL for Vaccine
Adverse Event Reporting System (VAERS) has changed to www.vaers.hhs.gov
- The URL for the
National Vaccine Injury Compensation Programs has changed.
This translation does not contain the
following CDC updates:- Most of the changes
to this VIS relate to the current exclusive use of the acellular
DTaP; the previous VIS included the whole-cell DTP, which is
no longer used in the U.S.
- Rates of reactions
(problems) that might be expected following DtaP have been
changed and are generally lower that those following DTP.
- The new URL for
the National Injury Compensation Program is listed. www.hrsa.gov/osp/vi
This translation does not contain the
following CDC updates:
- CDC changed the
indication to 1 year or older and has recommended routine use
for children.
- Section 2: Added
persons who work with primates or in research labs to indications
(routine vaccination).
- Added bullet for "persons
who live in communities that have prolonged outbreaks of hepatitis
A."
- Divided the section
into "Who" and "When" parts.
- Removed southern
Europe from list of regions with high rates of hepatitis A.
- Section 3: Added
bullet about allergy to vaccine component.
- Changed wording,
particularly the statement on pregnancy, and made list into
bullets.
- Minor changes to
part 4, 5, and 6 to be consistent with other recent VISs.
- Removed the section
on immune globulin.
This translation does not contain the
following CDC updates:
- The number of new
infections occurring annually is listed as 80,000 (previously
200,000).
- "Sharing of
needles" when injecting illegal drugs has been added as
a way of spreading the virus.
- The targeted groups
to be vaccinated has been expanded to include public safety
workers who might be exposed to infected blood or body fluids,
household contacts of persons with chronic HBV infection, and
hemodialysis patients.
- A time frame "in
6 months" has been added to the risk factor "people
who have more than one sex partner."
- Information about
the two-dose adolescent vaccine series has been added.
- The statement "Serious
allergic reactions are extremely rare with any vaccine" has
been added.
- The website of
Vaccine Adverse Event Reporting System has been added.
- A new URL for the
National Vaccine Injury Compensation Program is listed.
This translation does not contain the
following CDC updates:
- Female patients
are now advised to postpone pregnancy for 4 weeks after receiving
MMR vaccine (version 12/16/98 read "3 months").
- The website of
the Vaccine Adverse Event Reporting System has
been added.
- A new URL for the
National Vaccine Injury Compensation Program
has been added.
Thanks to
the Minnesota Department of Health for their translations.This page was updated on
March 13, 2008 |
|
|
IAC Home